Literature DB >> 7473513

Evolution of blockade of the renin-angiotensin system.

C I Johnston1, L M Burrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7473513

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  5 in total

Review 1.  A risk-benefit assessment of losartan potassium in the treatment of hypertension.

Authors:  L M Burrell
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.606

Review 2.  Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists.

Authors:  C Csajka; T Buclin; H R Brunner; J Biollaz
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

Review 3.  ACE inhibitors and the kidney. A risk-benefit assessment.

Authors:  G Navis; H J Faber; D de Zeeuw; P E de Jong
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 4.  Safety and tolerability of eprosartan in combination with hydrochlorothiazide.

Authors:  Michael Böhm; Alisia Sachse
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 5.  Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular disease.

Authors:  L M Burrell; C I Johnston
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 4.271
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.